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Background/Aims: Capsule endoscopy (CE) is widely used. However, CE has limitations including incomplete examination, 
inadequate bowel preparation, and retention. The aim of this study was to estimate the indications for and detection, completion, and 
retention rates of small intestine CE based on the 10-year data from the Korean Capsule Endoscopy Registry.
Methods: Twenty-four hospitals participated in this study. Clinical information, such as reasons for CE, method and quality of bowel 
preparation, and incomplete examination and capsule retention rates, was collected and analyzed. 
Results: A total of 2,914 CEs were registered. The most common reason for CE was obscure gastrointestinal bleeding (59%). Significant 
lesions were detected in 66% of cases. Positive CE diagnosis occurred in 63% of cases. The preparation method did not significantly affect the 
quality of bowel preparation for CE. The overall incomplete rate was 33%, and was high in the elderly and those with poor bowel preparation. 
Capsule retention was 3% and high in patients with small bowel tumors and Crohn’s disease and in children under 10 years of age.
Conclusions: CE is a valuable technique; while the overall detection rate is high, incompletion and retention rates are also relatively 
high. CE should be carefully considered in the elderly and children less than 10 years of age, as well as in patients with small bowel 
tumors and Crohn’s disease. Clin Endosc  2015;48:399-404
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INTRODUCTION
Capsule endoscopy (CE) is a noninvasive diagnostic tool 
used to visualize the small intestinal mucosa.1 It is a useful 
tool for investigating obscure gastrointestinal bleeding (OGIB), 
small bowel Crohn’s disease, polypoid syndrome, small bowel 
tumors, etc.1-3
Although CE has been shown to be superior to other tech-
niques for diagnosing small bowel lesions, complete small 
bowel examination is limited for various reasons.4 The lifespan 
of the batteries that power the capsule were previously limited 
to approximately 8 hours. For various reasons, some capsules 
cannot pass through the ileocecal valve before battery exhaus-
tion. In these cases, complete examination of the entire small 
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bowel is impossible. However, longer lifespan batteries have 
recently been developed.
To maximize the diagnostic yield of CE, adequate bowel 
preparation is important.4-6 The presence of impure intestinal 
juice or air bubbles can cause incomplete visualization of the 
intestinal mucosa and influence the diagnosis.7
Capsule retention is another complication of CE.8 Although 
retained capsules are usually asymptomatic, retention can 
potentially lead to symptomatic small bowel obstruction that 
often requires surgical or endoscopic intervention to remove 
the retained capsule.
CE has been performed as a primary diagnostic tool for 
small bowel disease at most medical centers in Korea. The aim 
of this study was to assess the indications for and detection, 
completion, and retention rates of CE based on 10 years of 
data from the Korean Capsule Endoscopy Registry. We also 
investigated factors affecting complete examination and cap-
sule retention. 
MATERIALS AND METHODS
A total of 2,914 CE examinations were enrolled in the cap-
sule registry from October 2002 to September 2012. CEs were 
performed at 24 hospitals across Korea. Information including 
age, gender, reasons for CE, CE findings (small bowel lesions), 
CE diagnosis, method and quality of bowel preparation, com-
plete examination, and retention was gathered by an Internet 
web site. Various CE instruments (PillCam SB1 and SB2, Giv-
en Imaging, Yokneam, Israel; MiroCam, IntroMedic Co., Ltd., 
Seoul, Korea; EndoCapsule, Olympus, Tokyo, Japan) were 
used.
The reasons for CE included OGIB, unexplained abdominal 
pain, chronic diarrhea, Crohn’s disease, small bowel tumor, 
ulcerative colitis, Behcet’s disease, ischemic enteritis, unknown 
origin of weight loss, cancer, and protein losing enteropathy. 
OGIB was defined as bleeding of unknown origin that per-
sisted or recurred after an initial upper and lower gastrointes-
tinal endoscopy with negative findings. In addition to cases 
of melena or hematochezia, persistent iron deficiency anemia 
or positive stool occult blood with negative findings on the 
initial endoscopy were also considered OGIB. CE findings 
and diagnoses were described based upon capsule endoscopy 
structured terminology. 
Before the CE study, each patient received bowel prepara-
tion according to clinician preference. The various methods 
of bowel preparation included nothing per os (NPO) for 12 
hours or use of purgative agents such as 2 or 4 L sodium 
phosphate (NaP) or polyethylene glycol (PEG) conducted 
in each hospital. Independent examiners categorized the 
quality of bowel preparation for CE. The quality the prepa-
rations were categorized as follows: excellent, visualization 
of ≥90% of the mucosa, no or minimal fluid, debris, and 
bubbles (Fig. 1A); good, visualization of ≥90% of the muco-
sa, mild fluid, debris, and bubbles (Fig. 1B); fair, visualization 
of <90% of the mucosa, moderate fluid, debris, and bubbles 
(Fig. 1C); poor, visualization of <80% of the mucosa, excessive 
fluid, debris, and bubbles (Fig. 1D).9,10
The overall incomplete and retention rates as well as the 
factors affecting completion and CE retention were investi-
gated. Completion was defined as the capsule reaching the ce-
cum during the recording time. Capsule retention was defined 
as the capsule remaining in the digestive tract for more than 2 
weeks. 
Statistical analysis
Data were represented as mean±standard deviation for 
continuous variables and number (%) for categorical data. 
Chi-square tests were used to evaluate the optimal method of 
bowel preparation. Multiple logistic regression models were 
used to identify the risk factors for completion and CE reten-
tion. Statistics were calculated using SAS 9.3 (SAS Institute, 
Inc., Cary, NC, USA).
A                                         B                                     C                                        D
Fig. 1. Quality of bowel preparation for capsule endoscopy. (A) Excellent, visualization of ≥90% of the mucosa, no or minimal fluid, debris, and bubbles. (B) Good, 
visualization of ≥90% of the mucosa, mild fluid, debris, and bubbles. (C) Fair, visualization of <90% of the mucosa, moderate fluid, debris, and bubbles. (D) Poor, visu-
alization of <80% of the mucosa, excessive fluid, debris, and bubbles.
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RESULTS
Demographic characteristics
The mean age of the entire study population was 53.0±17.6 
years, and male patients were predominant (61%). The reasons 
for CE are described in Table 1. The common reasons includ-
ed OGIB (59.3%), abdominal pain (17.1%), healthy volunteer 
(5.4%), suspected Crohn’s disease (3.6%), chronic diarrhea 
(3.5%), and small bowel tumor (2.9%).
CE findings and diagnosis
Lesions were detected in 66% of CE examinations, while 
normal findings were reported in 34% of procedures. Ulcers 
(20%), erosions (11%), and angiodysplasia (9%) were also 
common findings.
Positive CE diagnoses were obtained in 63% of exam-
inations. The most common CE diagnosis was small bowel 
tumor. Lymphangiectasia, lymphoid hyperplasia, lymphangi-
oma, polyp, submucosal tumor, and malignant tumor are all 
considered small bowel tumors. Vascular lesions, including 
angiodysplasia, telangiectasia, arteriovenous malformation, 
and dieulafoy lesions, were the second-most frequently di-
agnosed entity, followed by nonspecific ulcers (8%), erosions 
(6%), Crohn’s disease (6%), and non-steroidal anti-inflamma-
tory drug (NSAID) enteritis (5.3%) (Table 2).
Bowel preparation
PEG and NaP laxatives (80%) was more common used 
regimen for small bowel preparation for CE than NPO alone 
(20%). The 2 L PEG preparation was the most widely used 
preparation regimen in Korea for 10 years (52%; 1,123 of 2,143 
examinations). With adequate bowel preparation, the mucosa 
appeared clean for more than 90% of the total examinations, 
comprised of excellent and good quality and occupied 71.5% 
(1,532 of 2,143 examinations). The various preparation meth-
ods did not significantly affect the quality of bowel prepara-
tion for CE (p=0.64) (NPO for 12 hours compared to purga-
tive agents such as NaP and 2 or 4 L PEG) (Table 3).
Incomplete and retention rates
The overall incomplete rate was 33% (969/2,914). The mul-
tiple logistic regression model indicated that completion rates 
Table 1. Reasons for Capsule Endoscopy
Variable No. (%)
Obscure gastrointestinal bleeding 1,729 (59.3)
Overt 1,311 (44.9)
Occult 418 (14.1)
Abdominal pain 497 (17.1)
Crohn’s disease 105 (3.7)
Small bowel tumor 86 (2.9)
U lcerative colitis, Behcet’s disease, ischemic 
enteritis 
15 (0.5)
Weight loss 15 (0.1)
Cancer of unknown primary 4 (0.14)
Healthy volunteer 158 (5.8)
Chronic diarrhea 102 (3.5)
Protein losing enteropathy 3 (0.1)
Others 200 (6.8)
Table 2. Capsule Endoscopic Diagnosis 
Variable No. (%)
Normal 1,085 (37.2)
Vascular lesions 446 (15.3)
A ngiodysplasia, telangiectasia, arteriovenous 
malformation, Dieulafoy lesion
367 (12.39)
Bleeding of unidentified origin  72 (2.43)
Varices 7 (0.24)
Mucosal inflammatory lesions 828 (28.5)
Erosion, not signified 185 (6.24)
Ulcer, not signified 226 (7.63)
Hemorrhagic enteropathy 16 (0.54)
Congestive enteropathy 12 (0.4)
Henoch Schonlein purpura, vasculitis 7 (0.24)
Hemangioma 2 (0.07)
Behcet’s enteritis 20 (0.67)
Ischemic enteritis 4 (0.13)
Intestinal tuberculosis 10 (0.34)
Crohn’s disease 179 (6.04)
Ulcerative colitis 3 (0.1)
Radiation enteritis 8 (0.27)
Postsurgical stricture 3 (0.1)
NSAID enteritis 153 (5.16)
Tumor lesions 278 (9.5)
Lymphangiectasia 12 (0.4)
Lymphoid hyperplasia 19 (0.64)
Hemangioma 2 (0.07)
Lymphangioma 1 (0.03)
Polyp, adenomatous 9 (0.3)
Polyp, non-neoplastic 97 (3.27)
Tumor, malignant 35 (1.18)
Tumor, submucosal 103 (3.48)
Others 277 (9.5)
NSAID, non-steroidal anti-inflammatory drug.
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were significantly higher with better bowel preparation and 
high in patients with OGIB (Table 4). The incomplete rate was 
significantly higher in elderly patients.
The overall capsule retention rate was 3% (90/2,914). The 
rate was high in patients with small bowel tumors (5.7%) and 
Crohn’s disease (3.4%) (Table 5). The retention rate in children 
under 10 years was very high (8.3%). Capsule retention was 
significantly lower in cases with excellent bowel preparation 
(Table 6).
DISCUSSION
Since its first use 10 years ago, CE has been a first-line di-
agnostic method for evaluation of the small bowel. The most 
common indications for CE include OGIB, suspected Crohn’s 
disease, small bowel tumor, and polyposis syndrome. Howev-
er, healthy volunteers, unexplained abdominal pain, chronic 
diarrhea, weight loss, and unknown primary cancer were also 
common reasons for recommending CE in Korea during the 
10-year period. CE is a useful diagnostic modality: lesions are 
detected in 66% of cases, with a positive diagnostic rate of 
63%. However, CE has some limitations, such as inadequate 
bowel preparation and incompletion. To increase diagnosis 
yield, adequate bowel preparation and complete examination 
of the entire small bowel are important. Adequate bowel 
preparation is often difficult because lumen visualization is 
impaired by bubbles, bile, and debris.9,11 Previous recommen-
dations for CE preparation included a 12-hour fast after 24 
hours of clear liquid intake. However, fasting alone did not 
result in satisfactory bowel preparation. Current evidence 
Table 6. Risk Factor Analysis for Capsule Retention (Multiple Logistic Re-
gression Model)
Variable Odds ratio (95% CI) p-value 
Age 0.995 (0.983–1.008) 0.47
Sex 0.824 (0.519–1.308) 0.41
Reason for capsule endoscopy
 Obscure GI bleeding 0.359 (0.042–3.079) 0.98
 Crohn’s disease 0.491 (0.049–4.938) 0.99
 Small bowel tumor 0.114 (0.006–2.087) 0.99
 Abdominal pain 0.287 (0.032–2.601) 0.98
 Chronic diarrhea 0.239 (0.025–2.249) 0.97
Bowel preparation
Poor 1
Excellent 0.084 (0.027–0.259) 0.002
 Good 0.205 (0.108–0.388) 0.11
 Fair 0.373 (0.19–0.73) 0.20
CI, confidence interval; GI, gastrointestinal.
Table 3. Bowel Preparation Methods for Capsule Endoscopy 
Quality NPO (n=425) NaP (n=171) PEG 2 L (n=1,123)a) PEG 4 L (n=441)a)
Excellent   60 (14)    59 (34.5) 139 (12)   79 (18)
Good 234 (55) 86 (50) 630 (56) 245 (56)
Fair 108 (25) 21 (12) 285 (25)   86 (20)
Poor   19 (4.5) 5 (3) 62 (6) 25 (6)
Values are presented as number (%).
NPO, nothing per os; NaP, sodium phosphate; PEG, polyethylene glycol.
a)p=0.64.
Table 4. Risk Factors for Incompletion Rate (Multiple Logistic Regression 
Model) 
Variable Odds ratio (95% CI) p-value 
Age 0.99 (0.983–0.996) 0.002
Sex 1.13 (0.919–1.393) 0.24
Reason for capsule endoscopy
Obscure GI bleeding 1.67 (1.118–2.505) 0.002
Crohn’s disease 1.03 (0.561–1.885) 0.69
Small bowel tumor 1.49 (0.754–2.929) 0.30
Abdominal pain 1.27 (0.810–2.002) 0.41
Chronic diarrhea 0.33 (0.098–1.115) 0.93
Bowel preparation
Poor 1
Excellent 3.47 (2.300–5.248) 0.003
Good 4.64 (3.228–6.669) <0.001
Fair 2.49 (1.710–3.648) 0.016
CI, confidence interval; GI, gastrointestinal.
Table 5. Capsule Retention according to Reason for Capsule Endoscopy
Reason for capsule endoscopy Incidence, no. (%)
Obscure GI bleeding 11 (2.2)
Crohn’s disease 59 (3.4)
Small bowel tumor   6 (5.7)
Abdominal pain   1 (1.2)
Chronic diarrhea   1 (1.2)
Healthy control 0 
GI, gastrointestinal.
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suggests that laxatives containing PEG or NaP are more ef-
fective than fasting alone for improving visualization of small 
bowel mucosa.6,7 However, purgatives do not decrease gastric 
emptying or small bowel transit time.11 In the present study, 
there were no significant differences in the quality of bowel 
preparation between patients who used purgatives such as 
NaP and PEG and those who were NPO for 12 hours. The 
present study showed that poor bowel preparation was sig-
nificantly associated with increased incompletion and capsule 
retention rates. The method, dose, and time of administration 
for attaining the best quality small bowel images remain to be 
determined. 
In the present study, the incomplete small bowel examina-
tion rate was higher (33%) than in previous studies (20% to 
30%).12 This discrepancy may be due to subject traits such as 
age, underlying disease, delayed gastric emptying, and bowel 
preparation. Battery exhaustion can easily occur in patients 
with delayed gastric emptying, namely due to the capsule 
failing to enter the duodenum or remaining in the stomach 
for more than 1.5 hours. However, incompletion rates are ex-
pected to fall with development of longer-lived batteries (up 
to 13 to 16 hours). The MiroCam has battery that permits 9 to 
11 hours of transmission while the PillCam SB1, SB2, and En-
doCapsule offer 7 to 8 hours of transmission.13 In these study, 
incompletion rate did not differ according to device manufac-
turer. Older age, male gender, Crohn’s disease, and tumors are 
factors known to affect incomplete CE examination rates.14 
The results of the present study indicate that older age and 
poor bowel preparation may affect incomplete examination 
rates. One limitation of the present study was the lack of data 
regarding gastric transit time, which is a crucial factor in in-
complete examinations.
Retention rates reported in previous studies ranged from 
1.3% to 2.5%.12 The risk of retention is high in patients with 
prolonged NSAID use, abdominal radiation injury, exten-
sive Crohn’s disease, and previous major abdominal surgery 
or small-bowel resection.12,15 A recent large study reported a 
retention rate of 1.4%, finding NSAIDs enteropathy to be the 
main reason for retention.16 However, in the present study, the 
capsule retention rate was 3% (90/2,914) and often occurred in 
cases of small bowel tumor (5.7%), Crohn’s disease (3.4%) and 
in children under 10 years of age (8.3%). 
Both the incomplete examination (33%) and capsule reten-
tion (3%) rates were relatively higher than those reported in 
previous studies.16-19 One possible explanation could be patient 
age and disease distribution. In a large multicenter study, small 
bowel tumors were associated with capsule retention (9.8%).19 
In the present study, small bowel tumors were identified as 
high-risk factors for capsule retention (5.7%). 
There is still no accepted method to prevent capsule reten-
tion. The Agile patency capsule (Given Imaging) can dramati-
cally reduce retention rates when pretest suspicion is high.8
The strength of this study is that it is the largest study to 
estimate the indications for and detection, completion, and 
retention rates of small bowel CE in Korea over 10 years. 
However, this study has some limitations. First, this is a retro-
spective analysis. Second, there might be differences in inter-
pretation of CE findings between institutions. Third, because 
data were selected from the registry, selection bias is possible. 
Although both incomplete examination and capsule retention 
rates (33% and 3%, respectively) were relatively high, CE is a 
useful diagnostic tool with a high detection rate. Poor bowel 
preparation and old age were significantly associated with 
incompletion. To reduce capsule retention rates, CE examina-
tion should be carefully considered in patients suspected to 
have small bowel tumors and Crohn’s disease, and in children 
less than 10 years of age.
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